Number of Shares
6.24 Mil
Current Holdings Value*
$209.29 Mil
% of Portfolio
2.02%
Total Estimate Gain
$36.43 Mil
% of Total Estimate Gain
20.49%

DRIEHAUS CAPITAL MANAGEMENT LLC's Crinetics Pharmaceuticals Inc Holding Summary

As of 2025-03-31, DRIEHAUS CAPITAL MANAGEMENT LLC held 6.24 Mil shares of Crinetics Pharmaceuticals Inc(CRNX), totaling $209.29 Mil. This investment constitutes 2.02% of their stock portfolio, and DRIEHAUS CAPITAL MANAGEMENT LLC now holds 6.66% of the outstanding Crinetics Pharmaceuticals Inc(CRNX) stock.

The initial trade took place in 2020Q2. And since then DRIEHAUS CAPITAL MANAGEMENT LLC has made 14 purchases of CRNX, at an average price of $25.11, for a total of 7.08 Mil shares. In addition, there have been 6 sales at an average price of $29.15 for 839,415.00 shares. Based on historical transaction data and CRNX's current price of $30.41, DRIEHAUS CAPITAL MANAGEMENT LLC's estimated gain on his CRNX holdings is $36.43 Mil, reflecting a 20.49% gain to date.

DRIEHAUS CAPITAL MANAGEMENT LLC CRNX ($30.41) Holding Chart

DRIEHAUS CAPITAL MANAGEMENT LLC CRNX ($30.41) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1